• $41.7M
    Market Cap
  • -43.00%
    1-Year Change
  • Chemicals
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 25
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

Gabelli Funds to Host 3rd Annual PFAS Symposium at The Harvard Club, New York, NY

Gabelli Funds will host a symposium exploring PFAS (Per- and Polyfluoroalkyl Substances), bringing together experts to discuss environmental and public health challenges related to these persistent 'forever chemicals'.

08/28/2025, 8:00 AM • GlobeNewswire

Peers

Statistics

More
Day Range
$0.10
$0.12
$0.12
1-Year Range
$0.10
$0.23
$0.12
Latest Close$0.12
Change
+$0.02 (+15.24%)
Volume1,070,425
Market Cap$41.7M
Shares Outstanding320.9M
P/E (TTM)-2.42
Diluted EPS (TTM)-$0.05
Enterprise Value$39.2M

Information as of 06/03/2026

Company Profile

$41.7M
Market Cap
-$16.7M
Net Income
Sector: Basic Materials
Industry: Chemicals
14921 Chestnut Street, Westminster, CA, United States, 92683
888 400 2863

BioLargo, Inc. invents, develops, and commercializes various platform technologies in the United States. The company's technologies solve challenging environmental problems comprising per- and polyfluoroalkyl substances (PFAS) water contamination; advanced water and wastewater treatment; industrial odor and volatile organic compounds control, air quality control, and infection control; and myriad environmental remediation. It provides full-service environmental engineering, battery energy storage, and advanced antimicrobial medical device platforms. BioLargo, Inc. is based in Westminster, California.

Key Executives

  • Dennis Calvert
  • Kenneth Reay Code
  • Joseph L. Provenzano
  • Steven V. Harrison
  • Richard Smith

Current Ownership Distribution

  • Other233.1M (72.64%)
  • Insiders86.0M (26.81%)
  • Institutions1.8M (0.55%)
  • Mutual Funds0 (0.00%)